Why it Might Be Time to Eliminate Genomic Patents, Together with the Natural Extracts Doctrine Supporting Such Patents

97 Pages Posted: 20 Aug 2010 Last revised: 30 Mar 2013

See all articles by Allen K. Yu

Allen K. Yu

Center for Internet and Society

Date Written: April 1, 2007

Abstract

The purpose of recognizing enforceable rights in intellectual property in the United States is to “promote the progress of science and useful arts.” Given the changing landscapes of technologies, it is critical that policies and laws be continually adjusted to reflect the needs of new technologies. When the law tries to shield from – rather than confront – new technological realities, patents subvert rather than promote technological progress. This paper explores how the natural extracts doctrine, established over a century ago to allow purified compounds to be patented at a time when biochemistry was more alchemy than science, subverts rather than promotes progress in the modern biotechnological context. This paper argues that the natural extracts doctrine, together with the various isolation-based product patents – including gene product patents – that it has spawned, must be promptly abandoned or at least radically reduced in scope. Such patents not only violate the prohibition against the patenting of nature, but are also not commensurate with the underlying contributions made to the arts. In a proper patent regime, incentives given for today’s innovation should be appropriate for today's innovations, and not be given at the expense of tomorrow’s incentives. The paper concludes by offering a glimpse of what a patent system without the natural extracts doctrine might look like. It shows how a reinvigorated subject matter requirement and enablement requirement can properly incentivize innovations in biotechnology – sustainably and for the long term – without impeding the future.

Keywords: gene patents, subject matter eligibility, patents. 35 u.s.c. 101, natural products, patentability, Gottschalk v. Benson, Parker v. Flook, Diamond v. Diehr, Bilski v. Kappos

JEL Classification: O34

Suggested Citation

Yu, Allen K., Why it Might Be Time to Eliminate Genomic Patents, Together with the Natural Extracts Doctrine Supporting Such Patents (April 1, 2007). IDEA: The Journal of Law and Technology, Vol. 47, No. 5, 2007. Available at SSRN: https://ssrn.com/abstract=1660749

Allen K. Yu (Contact Author)

Center for Internet and Society ( email )

Stanford, CA 94305
United States

Register to save articles to
your library

Register

Paper statistics

Downloads
55
Abstract Views
648
rank
367,273
PlumX Metrics